Author details

Full Name

Angelina D Tan

Affiliation

Mayo Clinic

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35297944	Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).	JAMA Oncol	2022
35945621	Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience.	Trials	2022
31605793	A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.	J Thorac Oncol	2020
31872928	A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).	Oncologist	2020
32677021	Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy.	J Patient Rep Outcomes	2020
32470440	Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial.	Lancet Haematol	2020
32328844	A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.	Invest New Drugs	2020
30602311	Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.	Am J Hosp Palliat Care	2019
31590108	Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial.	Breast	2019
31605327	Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).	Ann Surg Oncol	2019
30985599	A Case Management System for Integrating Patient-reported Outcome Assessment in Clinical Practice: The Beacon Tool.	Med Care	2019
30990550	Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.	JAMA	2019
30550729	Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant.	Hematol Oncol Stem Cell Ther	2019
27838777	A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.	Support Care Cancer	2017
28247313	Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.	Qual Life Res	2017
28089762	Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).	J Thorac Oncol	2017
27101728	Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).	Ann Thorac Surg	2016
28691116	QOL and Survival Comparisons by Race in Oncology Clinical Trials.	J Cancer Clin Oncol	2016
27101729	A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).	Ann Thorac Surg	2016
25500100	Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.	J Thorac Cardiovasc Surg	2015
26526218	Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.	SOJ Anesthesiol Pain Manag	2015
26096694	Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.	Cancer	2015
26108458	A new scoring system for predicting survival in patients with non-small cell lung cancer.	Cancer Med	2015
25749740	Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).	Osteoporos Int	2015
24982457	Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.	J Clin Oncol	2014
23998400	Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.	Ann Thorac Surg	2013
24114122	UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.	Invest New Drugs	2013
24265598	A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care.	PLoS Med	2013
23887852	Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.	Invest New Drugs	2013
23218084	Association of resident fatigue and distress with occupational blood and body fluid exposures and motor vehicle incidents.	Mayo Clin Proc	2012
21872277	Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.	J Thorac Cardiovasc Surg	2011
19546817	Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.	J Thorac Oncol	2009
19773564	Association of resident fatigue and distress with perceived medical errors.	JAMA	2009
17598133	Levetiracetam for the treatment of hot flashes: a phase II study.	Support Care Cancer	2008
17909811	A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.	Cancer Chemother Pharmacol	2008
16763792	A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.	Cancer Chemother Pharmacol	2007
17762343	Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer.	J Thorac Oncol	2007
17761129	Pilot evaluation of flaxseed for the management of hot flashes.	J Soc Integr Oncol	2007
17123268	The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.	Cancer	2007
17123880	Analyzing the "correct" endpoint.	Curr Probl Cancer	2006

1 - 40 of 40

Michael A Golafshar

Mayo Clinic

Career Start Year 2018

Number of shared co-authors 1

Holly E Hartman

Case Western Reserve University

Career Start Year 2018

Number of shared co-authors 0

Donna R Rivera

Oncology Center of Excellence

Career Start Year 2012

Number of shared co-authors 0

Jyoti Malhotra

Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School

Career Start Year 2012

Number of shared co-authors 0

Lawson Eng

Princess Margaret Cancer Centre, University Health Network, University of Toronto

Career Start Year 2011

Number of shared co-authors 0

Christine Massey

Princess Margaret Cancer Centre

Career Start Year 2010

Number of shared co-authors 0

Chen Hu

Johns Hopkins University School of Medicine

Career Start Year 2009

Number of shared co-authors 2

Kelley M Kidwell

University of Michigan School of Public Health ann arbor

Career Start Year 2009

Number of shared co-authors 0

Sunita Ghosh

Cross Cancer Institute

Career Start Year 2006

Number of shared co-authors 0

Nora Horick

Massachusetts General Hospital

Career Start Year 2003

Number of shared co-authors 1

Gregory R Pond

Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute

Career Start Year 2001

Number of shared co-authors 1

Hanneke W M van Laarhoven

Cancer Center Amsterdam

Career Start Year 2001

Number of shared co-authors 0

Drew Moghanaki

University of California Los Angeles

Career Start Year 2000

Number of shared co-authors 0

Pingfu Fu

Case Western Reserve University

Career Start Year 2000

Number of shared co-authors 0

Elisabeth I Heath

Karmanos Cancer Center, Wayne State University

Career Start Year 1999

Number of shared co-authors 0

Thomas J George

UF Health Cancer Center

Career Start Year 1998

Number of shared co-authors 2

David Elashoff

David Geffen School of Medicine at University of California los angeles

Career Start Year 1997

Number of shared co-authors 1

Elizabeth Garrett-Mayer

Center for Research and Analytics, American Society of Clinical Oncology

Career Start Year 1997

Number of shared co-authors 2

Katherine S Panageas

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 1

Craig C Earle

Odette Cancer Centre

Career Start Year 1996

Number of shared co-authors 0

Puneeth Iyengar

UT Southwestern Medical Center, Center for Human Nutrition

Career Start Year 1996

Number of shared co-authors 1

Deborah Schrag

Memorial-Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 5

Alexandra L Hanlon

Virginia Tech

Career Start Year 1994

Number of shared co-authors 0

Michael Brundage

Cancer Centre of Southeastern Ontario

Career Start Year 1993

Number of shared co-authors 2

Jeffrey Peppercorn

Massachusetts General Hospital, Harvard Medical School

Career Start Year 1993

Number of shared co-authors 2

Madhu Mazumdar

Icahn School of Medicine at Mount Sinai

Career Start Year 1992

Number of shared co-authors 0

Vera J Suman

Mayo Clinic

Career Start Year 1992

Number of shared co-authors 14

Deborah W Bruner

Emory University, USA Winship Cancer Institute, USA School of Medicine

Career Start Year 1987

Number of shared co-authors 2

Kenneth R Hess

The University of Texas MD Anderson Cancer Center

Career Start Year 1986

Number of shared co-authors 1

Edward Chow

University of Toronto

Career Start Year 1983

Number of shared co-authors 0

row(s) 1 - 30 of 30

Jeff A Sloan

Mayo Clinic

Co-authored papers 14

Paul J Novotny

Mayo Clinic

Co-authored papers 6

Charles L Loprinzi

Mayo Clinic

Co-authored papers 5

Ping Yang

Mayo Clinic

Co-authored papers 2

Tait D Shanafelt

Stanford Cancer Institute, Stanford University

Co-authored papers 2

Helen J Ross

Mayo Clinic

Co-authored papers 2

Kathleen J Yost

Mayo Clinic

Co-authored papers 1

Kathryn J Ruddy

Mayo Clinic

Co-authored papers 1

Jann N Sarkaria

Co-authored papers 1

Jasvinder A Singh

University of Alabama at Birmingham

Co-authored papers 1

Carmen Radecki Breitkopf

Mayo Clinic

Co-authored papers 1

Steven A Smith

Mayo Clinic

Co-authored papers 1

Victor M Montori

Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic

Co-authored papers 1

Jeanette Y Ziegenfuss

HealthPartners Institute

Co-authored papers 1

Jennifer L Ridgeway

Mayo Clinic

Co-authored papers 1

Phuong Nguyen

Hoag Memorial Hospital Presbyterian

Co-authored papers 1

Steven R Alberts

Mayo Clinic

Co-authored papers 1

Matthew P Goetz

Mayo Clinic

Co-authored papers 1

Timothy J Beebe

University of Minnesota School of Public Health

Co-authored papers 1

Christopher G Chute

Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota

Co-authored papers 1

Aditya Bardia

Massachusetts General Hospital Cancer Center

Co-authored papers 1

Alex Alexander

Center for the Science of Health Care Delivery.

Co-authored papers 1

Robert W Williams

Mayo Clinic

Co-authored papers 1

Kelly K Hunt

The University of Texas MD Anderson Cancer Center